NasdaqCM - Nasdaq Real Time Price USD
Kezar Life Sciences, Inc. (KZR)
4.1200
+0.0400
+(0.98%)
At close: May 8 at 4:00:01 PM EDT
4.1200
0.00
(0.00%)
After hours: May 8 at 4:00:13 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-74,212
-74,212
-81,645
-58,846
-42,437
Investing Cash Flow
80,428
80,428
76,046
-91,392
-28,444
Financing Cash Flow
103
103
638
127,861
112,585
End Cash Position
41,749
41,749
35,493
40,456
62,882
Interest Paid Supplemental Data
1,335
1,335
1,315
973
69
Capital Expenditure
-29
-29
-1,810
-1,578
-316
Issuance of Capital Stock
0
0
0
126,542
100,970
Issuance of Debt
--
--
0
0
9,531
Free Cash Flow
-74,241
-74,241
-83,455
-60,424
-42,753
12/31/2021 - 6/21/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9100
+3.24%
EPIX ESSA Pharma Inc.
1.7100
-1.16%
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%
RPTX Repare Therapeutics Inc.
1.3600
0.00%
IPSC Century Therapeutics, Inc.
0.5200
-0.34%
SPRO Spero Therapeutics, Inc.
0.5750
-0.52%
LVTX LAVA Therapeutics N.V.
1.2700
+1.60%
PMVP PMV Pharmaceuticals, Inc.
0.8838
-0.67%
TBPH Theravance Biopharma, Inc.
9.90
-0.90%
GLTO Galecto, Inc.
2.8400
+4.80%